- Registration, Cancellation policy, Scholarships
- Auditorium Maximum UJ
Organizing / Scientific Committee
Course Director: Janusz Ryś MD. PhD. Members: Agnieszka Adamczyk PhD.Artur Bartczak MD.Agnieszka Klimkowska PhD.Jan Klos MD.Artur Kowalik PhD.Anna Kruczak PhD.Krzysztof…
Language, Participants
Language: The language of the course is English. Participants: The target groups are consultant pathologists and pathologists in training. The…
Venue, Travel, Contact
Auditorium Maximum of the Jagiellonian UniversityKrupnicza 33, Kraków(17-19th April 2024) Travel The old city of Krakow is a tourist attraction…
Registration, Cancellation policy, Scholarships
Registration fee: Participant 2500.00 PLN Registration: Cancellation policy: After 31st of March 2024 no refunds of course fee will be…
Program
PDF file can be downloaded from the top menu.
- 09.00 – 10.00
Registration and coffee
- 10.00 – 10.10
Introduction – J. Ryś
- 10.10 – 11.10
Technology in Immunohistochemistry – S. Nielsen
- 11.10 – 12.00
Interpretation Pitfalls – J. Klos
- 12.00 – 13.00
Lunch (60’)
- 13.00 – 14.15
The role of Immunohistochemistry and Molecular Pathology in Diagnosing Tumors of the Lower Genital Tract – B. Davidson
- 14.15 – 15.00
Endometrial Carcinoma, What You Need to Know Now – A. Malpica
- 15.00 – 15.30
Coffee
- 15.30 – 16.30
Ovarian and Fallopian Tube Tumors, Soundbites – A. Malpica
- 16.30 – 17.30
Current challenges and practical aspects of the immunohistochemistry and molecular pathology of rare gynecological mesenchymal tumors (sarcomas). – P. Dundr
- 08.30 – 09.15
Histological, Immunohistochemical and Molecular Subtypes of TNBC – G. Cserni
- 09.15 – 10.00
HER2- High and Low Breast Cancer – T. Tot
- 10.00 – 10.30
Coffee (30’)
- 10.30 – 11.15
Histological, Immunohistochemical and Molecular Approach to Differential Diagnosis of Pulmonary Malignant Neoplasms – A. Nicholson
- 11.15 – 12.00
IHC based predictive biomarkers for solid tumors (novel PD-L1 applications, claudin 18 and Ceacam 5) – H-U. Schildhaus
- 12.00 – 12.30
Tuft Cell-like Carcinoma. The New Kid on the Block – J. Lasota
- 12.30 – 13.30
Lunch (60’)
- 13.30 – 14.15
Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. – M. Miettinen
- 14.15 – 15.00
Optical Genome Mapping for comprehensive cytogenetic analysis of soft tissue and bone tumours. – M. Dębiec-Rychter
- 15.00 – 15.30
Coffee (30’)
- 15.30 – 16.15
Publicly available genomic datasets – an important resource for precision oncology – M. Dębiec-Rychter
- 16.15 – 17.45
Consultation corner (10 – 12 cases) – A. Malpica, B. Davidson, M. Miettinen
- 08.30 – 09.15
Targeted therapies with companion diagnostics in the management of cancer patients: future perspectives. – I. Ługowska
- 09.15 – 10.00
Next generation molecular board for functional precision medicine. – M. Kamal
- 10.00 – 10.30
Coffee (30’)
- 10.30 – 11.15
Cancer of unknown origin. – A. Bellizzi
- 11.15 – 12.00
Cancers of Unknown Primary Site: Clinical and Molecular Approach. – K. Tałasiewicz
- 12.00 – 13.00
Lunch (60’)
- 13.00 – 13.45
Immunohistochemical detection of predictive biomarkers for molecularly targeted therapies and immunotherapies. – J. Lasota
- 13.45 – 14.30
Immunohistochemistry of Head and Neck tumors. – A. Bellizzi
- 14.30 – 15.00
Coffee (30’)
- 15.00 – 15.30
AI and Digital Pathology – K. Korski
- 15.30 – 16.00
Digital analysis of predictive factors in breast cancer – A. Kowalewski
- 16.00 – 16.15
Summary and conclusions – J. Ryś
- 17th April 2024, 19.00 – 22.00
Dinner for participants by the invitation and sponsorship of the Mayor of the City of Krakow *
-
* Declaration from the Organizers: No resources from INFARMA associated companies are involved.
Roche
-
Roche Diagnostics Polska focuses on introducing innovative and reliable solutions in the field of clinical diagnostics and biomedical research. An important area of the company’s activities is supporting oncology diagnostics by providing solutions dedicated to both in vitro diagnostics and research purposes. Modern diagnostic solutions: tests, reagents, analysers and instruments, as well as digital solutions, are present in virtually every hospital, laboratory and pathomorphology department. The company offers a range of innovative solutions applicable in oncology diagnostics, including Laboratory diagnostics: tumour markers, monitoring of therapy effectiveness. Pathomorphology diagnostics: slide staining systems: IHC and ISH, over 230 antibodies on offer (1) Digital pathomorphology: scanners for histopathology slides, algorithms to support pathomorphology workflow and remote consultation. Molecular diagnostics: broad portfolio of oncology tests, digital PCR technology. Next-generation sequencing: library preparation, target enrichment, panel designer, comprehensive genomic profiling, secondary and tertiary analysis Bioinformatics solutions: navify platform.
1. https://www.roche.pl/rozwiazania/diagnostyczne available 02.04.2024
MC-PL-01045
Roche